Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. buy Snowman

Start price
€31.01
18.12.20 / 80%
Target price
€34.00
2021-12-18
Performance (%)
-5.91%
Price
€28.86
05.03.21
This prediction is currently active. With a performance of -5.91%, the BUY prediction for Pfizer Inc. by Snowman is down slightly. Dividends of €0.32 are taken into consideration when calculating the performance. This prediction currently runs until 2021-12-18. The prediction end date can be changed by Snowman at any time. Snowman has 80% into this prediction

According to Snowman what are the pros and cons of Pfizer Inc. for the foreseeable future?

Pros
Some uniques
Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
Small Risks for its business
Differentiated customer and product portfolio
Known brand
Market Leader or Top 3
Cons
Growths slower than the competition
Business model of the past or high risk

Comments by Snowman for this prediction

In the thread Pfizer Inc. diskutieren
Prediction Buy
Perf. (%) -5.91%
Target price 36.000
Change
Ends at 18.12.21

Buy mit Kursziel 36,0

Prediction Buy
Perf. (%) -5.91%
Target price 34.000
Change
Ends at 18.12.21

Kursziel geändert auf 34,0